Rocket Pharmaceuticals Statistics

Total Valuation

RCKT has a market cap or net worth of $333.42 million. The enterprise value is $87.13 million.

Market Cap	333.42M
Enterprise Value	87.13M

Important Dates

The last earnings date was Thursday, August 7, 2025, after market close.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

RCKT has 107.90 million shares outstanding. The number of shares has increased by 13.53% in one year.

Current Share Class	107.90M
Shares Outstanding	107.90M
Shares Change (YoY)	+13.53%
Shares Change (QoQ)	+0.84%
Owned by Insiders (%)	2.75%
Owned by Institutions (%)	66.01%
Float	81.10M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	2.60
PB Ratio	0.94
P/TBV Ratio	1.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.07.

Current Ratio	6.39
Quick Ratio	6.26
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-139.85

Financial Efficiency

Return on equity (ROE) is -69.65% and return on invested capital (ROIC) is -41.81%.

Return on Equity (ROE)	-69.65%
Return on Assets (ROA)	-38.07%
Return on Invested Capital (ROIC)	-41.81%
Return on Capital Employed (ROCE)	-69.97%
Revenue Per Employee	n/a
Profits Per Employee	-$860,532
Employee Count	299
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -83.69% in the last 52 weeks. The beta is 0.65, so RCKT's price volatility has been lower than the market average.

Beta (5Y)	0.65
52-Week Price Change	-83.69%
50-Day Moving Average	2.96
200-Day Moving Average	8.36
Relative Strength Index (RSI)	50.40
Average Volume (20 Days)	3,249,681

Short Selling Information

The latest short interest is 11.23 million, so 10.41% of the outstanding shares have been sold short.

Short Interest	11.23M
Short Previous Month	12.90M
Short % of Shares Out	10.41%
Short % of Float	13.85%
Short Ratio (days to cover)	3.38

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-264.18M
Pretax Income	-253.26M
Net Income	-257.30M
EBITDA	-253.87M
EBIT	-264.18M
Earnings Per Share (EPS)	-$2.49

Full Income Statement

Balance Sheet

The company has $271.49 million in cash and $25.20 million in debt, giving a net cash position of $246.29 million or $2.28 per share.

Cash & Cash Equivalents	271.49M
Total Debt	25.20M
Net Cash	246.29M
Net Cash Per Share	$2.28
Equity (Book Value)	354.21M
Book Value Per Share	3.28
Working Capital	233.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$203.80 million and capital expenditures -$2.31 million, giving a free cash flow of -$206.11 million.

Operating Cash Flow	-203.80M
Capital Expenditures	-2.31M
Free Cash Flow	-206.11M
FCF Per Share	-$1.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

RCKT does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.53%
Shareholder Yield	-13.53%
Earnings Yield	-77.17%
FCF Yield	-61.82%

Dividend Details

Analyst Forecast

The average price target for RCKT is $12.88, which is 316.83% higher than the current price. The consensus rating is "Buy".

Price Target	$12.88
Price Target Difference	316.83%
Analyst Consensus	Buy
Analyst Count	13
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-34.44%

Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1